BioNexus Gene Lab (BGLC) Non-Current Assets (2018 - 2026)

BioNexus Gene Lab's Non-Current Assets history runs 9 years deep, the most recent figure standing at $3.8 million for Q1 2026.

• In Q1 2026, Non-Current Assets rose 30.87% year-over-year to $3.8 million; the TTM figure through Mar 2026 stood at $3.8 million (up 30.87% YoY), while the FY2025 annual figure was $3.8 million, up 26.66% from the prior year.
• Non-Current Assets came in at $3.8 million for Q1 2026 at BioNexus Gene Lab, up from $3.8 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $4.0 million in Q3 2024 to a low of $2.0 million in Q3 2025.
• A 5-year average of $3.0 million and a median of $3.0 million in 2024 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets surged 33.75% in 2023 and slumped 49.58% in 2025, its largest moves.
• BioNexus Gene Lab's Non-Current Assets stood at $2.7 million in 2022, then rose by 23.35% to $3.4 million in 2023, then retreated by 10.43% to $3.0 million in 2024, then increased by 26.66% to $3.8 million in 2025, then advanced by 1.06% to $3.8 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $3.8 million, $3.8 million, and $2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison